Should clinical laboratories adapt to the reality of chronic kidney disease in the determination of parathyroid hormone?
The contribution of the clinical laboratory to diagnostics is increasingly important since a great deal of clinical decisions rely on laboratory test results.
Enregistré dans:
Auteurs principaux: | González-Casaus María Luisa, Fernández-Calle Pilar, Buño Soto Antonio |
---|---|
Format: | article |
Langue: | EN ES |
Publié: |
De Gruyter
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d2d268568e0e4b6d97fb9c4aaa1d1765 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Serum sirtuin 1 is independently associated with intact PTH among patients with chronic kidney disease
par: Bielach-Bazyluk A, et autres
Publié: (2021) -
¿Debemos adaptarnos los laboratorios clínicos a la realidad del paciente con enfermedad renal crónica en la cuantificación de la hormona paratiroidea?
par: González-Casaus María Luisa, et autres
Publié: (2021) -
Modulation of in vitro Osteoclast Activity Mediated by Different Doses of Parathyroid Hormone
par: Ginani,Fernanda, et autres
Publié: (2017) -
Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis
par: Pollock RF, et autres
Publié: (2013) -
The role of laboratory medicine specialists in the COVID-19 pandemic
par: Buño Soto Antonio
Publié: (2020)